Algoa Progress provides improved clinical diagnostic and osteoarthritis progression prediction tools, to assist healthcare practitioners, but also patients to optimize the best possible treatment strategy aiming to prevent the disease development or to slow down its progression.
It is the first solution providing a comprehensive personalized treatment journey from the first clinical visit to sustained quality of life. It is the first solution to predict and quantify the patient's osteoarthritis risk evolution and a visual demonstration of the prediction. In addition, It is the only solution to simulate and visualize the effects of personalized treatment interventions supporting planning the most effective prevention strategies.
The solution is currently under development by an international team consisting of experts in osteoarthritis research, artificial intelligence, clinical image analysis, and hospital data systems. We are expecting to launch the product to the markets during 2023.